Clinical Trials List
Protocol NumberM25-692
Active
2026-02-01 - 2028-12-31
Phase I
Not yet recruiting1
-
-
Trial Applicant
AbbVie
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/08
Investigators and Locations
Principal Investigator
MENG-YAO LU
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
18 participants
